← Back to Search

Eko Sensora Device for Heart Murmurs (EkoNM Trial)

Q: Can individuals currently access this clinical trial?

<p>The data posted on clinicaltrials.gov tells us that this trial is presently looking for volunteers; it was first announced on October 26th 2023 and its latest update occurred at the end of November 2023.</p>

Q: How many participants are actively involved in the experiment?

<p>Affirmative. Clinicaltrials.gov presents evidence that this investigation is still recruiting patients, having been initially posted on October 26th 2023 and most recently updated November 30th of the same year. 300 participants from a single site are requested for participation in the trial.</p>

Phase < 1

Recruiting

Research Sponsored by Spectrum Health - Lakeland

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 90 days

Awards & highlights

EkoNM Trial Summary

This trial will test a device that uses AI to detect heart abnormalities, improving the ability to identify cardiac dysfunction in emergency care. #medical #AI #heart #trial

Who is the study for?

This trial is for people over 50 with symptoms like chest pain or shortness of breath, and a history of conditions such as high blood pressure, obesity, diabetes, heart issues or stroke. It's not for those in isolation or under 18.Check my eligibility

What is being tested?

The Eko Sensora device is being tested to see if it can detect serious heart valve disease by recording heart sounds using AI technology in an emergency department setting.See study design

What are the potential side effects?

Since the Eko Sensora is a non-invasive digital stethoscope that uses sound recordings and AI analysis, there are no direct side effects from its use.

EkoNM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of new clinically significant heart murmurs detected

Secondary outcome measures

Number of echocardiograms ordered

EkoNM Trial Design

1Treatment groups

Experimental Treatment

Group I: Eko DeviceExperimental Treatment1 Intervention

Patients with cardiac risk factors

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Spectrum Health - LakelandLead Sponsor

12 Previous Clinical Trials

1,499 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals currently access this clinical trial?

"The data posted on clinicaltrials.gov tells us that this trial is presently looking for volunteers; it was first announced on October 26th 2023 and its latest update occurred at the end of November 2023."

Answered by AI

How many participants are actively involved in the experiment?

"Affirmative. Clinicaltrials.gov presents evidence that this investigation is still recruiting patients, having been initially posted on October 26th 2023 and most recently updated November 30th of the same year. 300 participants from a single site are requested for participation in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EKO SENSORA: Detecting Clinically Significant Murmurs

2023. "EKO SENSORA: Detecting Clinically Significant Murmurs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06155643.